annual EBITDA:
-$269.00M+$22.00M(+7.56%)Summary
- As of today (June 17, 2025), RCUS annual EBITDA is -$269.00 million, with the most recent change of +$22.00 million (+7.56%) on December 31, 2024.
- During the last 3 years, RCUS annual EBITDA has fallen by -$328.00 million (-555.93%).
- RCUS annual EBITDA is now -555.93% below its all-time high of $59.00 million, reached on December 31, 2021.
Performance
RCUS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$108.00M-$19.00M(-21.35%)Summary
- As of today (June 17, 2025), RCUS quarterly EBITDA is -$108.00 million, with the most recent change of -$19.00 million (-21.35%) on March 31, 2025.
- Over the past year, RCUS quarterly EBITDA has dropped by -$108.00 million (-100.00%).
- RCUS quarterly EBITDA is now -138.17% below its all-time high of $282.95 million, reached on December 31, 2021.
Performance
RCUS quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$377.00M-$108.00M(-40.15%)Summary
- As of today (June 17, 2025), RCUS TTM EBITDA is -$377.00 million, with the most recent change of -$108.00 million (-40.15%) on March 31, 2025.
- Over the past year, RCUS TTM EBITDA has dropped by -$161.00 million (-74.54%).
- RCUS TTM EBITDA is now -519.10% below its all-time high of $89.95 million, reached on September 30, 2022.
Performance
RCUS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RCUS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.6% | -100.0% | -74.5% |
| 3 y3 years | -555.9% | -63.6% | -681.9% |
| 5 y5 years | -231.6% | -294.0% | -315.5% |
RCUS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -555.9% | +7.6% | <-9999.0% | at low | -519.1% | at low |
| 5 y | 5-year | -555.9% | +7.6% | -138.2% | at low | -519.1% | at low |
| alltime | all time | -555.9% | +7.6% | -138.2% | at low | -519.1% | at low |
RCUS EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$108.00M(+21.3%) | -$377.00M(+40.1%) |
| Dec 2024 | -$269.00M(-7.6%) | -$89.00M(0.0%) | -$269.00M(+4.7%) |
| Sep 2024 | - | -$89.00M(-2.2%) | -$257.00M(+9.4%) |
| Jun 2024 | - | -$91.00M(<-9900.0%) | -$235.00M(+8.8%) |
| Mar 2024 | - | $0.00(-100.0%) | -$216.00M(-25.8%) |
| Dec 2023 | -$291.00M(+12.8%) | -$77.00M(+14.9%) | -$291.00M(+4.3%) |
| Sep 2023 | - | -$67.00M(-6.9%) | -$279.00M(+1.5%) |
| Jun 2023 | - | -$72.00M(-4.0%) | -$275.00M(+3.0%) |
| Mar 2023 | - | -$75.00M(+15.4%) | -$267.00M(+3.5%) |
| Dec 2022 | -$258.00M(-537.3%) | -$65.00M(+3.2%) | -$258.00M(-386.8%) |
| Sep 2022 | - | -$63.00M(-1.6%) | $89.95M(+18.5%) |
| Jun 2022 | - | -$64.00M(-3.0%) | $75.94M(+17.2%) |
| Mar 2022 | - | -$66.00M(-123.3%) | $64.79M(+9.8%) |
| Dec 2021 | $59.00M(-149.2%) | $282.95M(-467.4%) | $59.00M(-121.5%) |
| Sep 2021 | - | -$77.01M(+2.5%) | -$274.65M(+40.8%) |
| Jun 2021 | - | -$75.15M(+4.7%) | -$195.09M(+18.7%) |
| Mar 2021 | - | -$71.79M(+41.6%) | -$164.38M(+37.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$120.00M(+47.9%) | -$50.70M(-2086.7%) | -$120.00M(+46.4%) |
| Sep 2020 | - | $2.55M(-105.7%) | -$81.97M(-23.3%) |
| Jun 2020 | - | -$44.44M(+62.1%) | -$106.89M(+17.8%) |
| Mar 2020 | - | -$27.41M(+116.3%) | -$90.73M(+11.8%) |
| Dec 2019 | -$81.13M(+58.5%) | -$12.67M(-43.3%) | -$81.13M(+0.2%) |
| Sep 2019 | - | -$22.36M(-20.9%) | -$81.00M(+16.0%) |
| Jun 2019 | - | -$28.28M(+58.7%) | -$69.81M(+23.5%) |
| Mar 2019 | - | -$17.82M(+42.1%) | -$56.51M(+10.4%) |
| Dec 2018 | -$51.20M(+0.7%) | -$12.54M(+12.2%) | -$51.20M(-0.1%) |
| Sep 2018 | - | -$11.17M(-25.4%) | -$51.24M(-18.0%) |
| Jun 2018 | - | -$14.98M(+19.8%) | -$62.47M(+10.5%) |
| Mar 2018 | - | -$12.50M(-0.6%) | -$56.52M(+11.2%) |
| Dec 2017 | -$50.83M(+201.3%) | -$12.58M(-43.9%) | -$50.83M(+32.9%) |
| Sep 2017 | - | -$22.40M(+147.9%) | -$38.25M(+141.3%) |
| Jun 2017 | - | -$9.04M(+32.6%) | -$15.85M(+132.6%) |
| Mar 2017 | - | -$6.81M | -$6.81M |
| Dec 2016 | -$16.87M | - | - |
FAQ
- What is Arcus Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Arcus Biosciences?
- What is Arcus Biosciences annual EBITDA year-on-year change?
- What is Arcus Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Arcus Biosciences?
- What is Arcus Biosciences quarterly EBITDA year-on-year change?
- What is Arcus Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Arcus Biosciences?
- What is Arcus Biosciences TTM EBITDA year-on-year change?
What is Arcus Biosciences annual EBITDA?
The current annual EBITDA of RCUS is -$269.00M
What is the all time high annual EBITDA for Arcus Biosciences?
Arcus Biosciences all-time high annual EBITDA is $59.00M
What is Arcus Biosciences annual EBITDA year-on-year change?
Over the past year, RCUS annual EBITDA has changed by +$22.00M (+7.56%)
What is Arcus Biosciences quarterly EBITDA?
The current quarterly EBITDA of RCUS is -$108.00M
What is the all time high quarterly EBITDA for Arcus Biosciences?
Arcus Biosciences all-time high quarterly EBITDA is $282.95M
What is Arcus Biosciences quarterly EBITDA year-on-year change?
Over the past year, RCUS quarterly EBITDA has changed by -$108.00M (-100.00%)
What is Arcus Biosciences TTM EBITDA?
The current TTM EBITDA of RCUS is -$377.00M
What is the all time high TTM EBITDA for Arcus Biosciences?
Arcus Biosciences all-time high TTM EBITDA is $89.95M
What is Arcus Biosciences TTM EBITDA year-on-year change?
Over the past year, RCUS TTM EBITDA has changed by -$161.00M (-74.54%)